Related Experiment Video

Updated: May 10, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Promoter methylation and expression of TIMP3 gene in gastric cancer

ZhiYu Guan1, Jun Zhang, ShiHui Song

  • 1Department of Cardiovascular and Thoracic Surgery, TianJin Medical University General Hospital, 154 AnShan Road, HePing Section, TianJin 300052, China. guanzy69@163.com

Diagnostic Pathology
|July 4, 2013
PubMed
Abstract

Insights

Hypermethylation of the tissue inhibitor of metalloproteinase 3 (TIMP3) gene is linked to reduced protein expression in gastric adenocarcinoma. This epigenetic change is a key mechanism in gastric cancer development and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Gastric carcinoma arises from multi-gene alterations, with aberrant DNA methylation inactivating anti-oncogenes.
  • Tissue inhibitor of metalloproteinase 3 (TIMP3) gene inactivation is crucial in tumor development.
  • This study investigates the link between TIMP3 promoter CpG island methylation, protein expression, and gastric adenocarcinoma features.

Purpose of the Study:

  • To assess the relationship between aberrant methylation of the TIMP3 gene promoter CpG islands and its protein expression.
  • To correlate these findings with the clinicopathological features of gastric adenocarcinoma.
  • To explore the role of TIMP3 methylation in gastric cancer development.

Main Methods:

  • Analyzing TIMP3 promoter CpG island methylation using methylation-specific PCR (MSP).
  • Evaluating TIMP3 protein expression via immunohistochemistry.
  • Examining tissues from 78 gastric adenocarcinoma patients and adjacent normal mucosa.

Main Results:

  • TIMP3 hypermethylation was detected in tumor tissues (35.9%-100%), cancer-adjacent tissues, and metastatic lymph nodes, significantly differing from non-neoplastic tissues (P<0.05).
  • TIMP3 protein expression was down-regulated in tumor tissues, decreasing with cancer stage (100% in normal, 30% early, 3.4% progressive, 0% metastatic).
  • A strong association (P<0.01) was found between TIMP3 hypermethylation and reduced/negative protein expression (91.4% of negative cases were hypermethylated).

Conclusions:

  • Aberrant hypermethylation of the TIMP3 promoter CpG islands is the primary mechanism for TIMP3 gene silencing in gastric cancer.
  • These findings suggest TIMP3 methylation status can serve as a biomarker for molecular diagnosis and stage evaluation in gastric cancer.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...